Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical Examination for the Prediction of Mortality in the Critically Ill: The Simple Intensive Care Studies-I

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation and Clinical Evaluation of a Method for Double-Blinded Blood Pressure Target Investigation in Intensive Care Medicine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Platelet Transfusion Practices in Critically Ill Children

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
OBJECTIVE: Soluble CD163 (sCD163) is a new macrophage-specific serum marker. This study investigated sCD163 and other markers of macrophage activation (neopterin, ferritin, transcobalamin, and soluble urokinase plasminogen activator receptor [suPAR]) as prognostic factors in patients with pneumococcal bacteremia. DESIGN: Observational cohort study. SETTING: Five university hospitals in Denmark. PATIENTS: A total of 133 patients with Streptococcus pneumoniae bacteremia (positive blood culture) and 133 age- and gender-matched controls. INTERVENTIONS: Samples were collected for biochemical analyses at the time of first positive blood culture. MEASUREMENTS AND MAIN RESULTS: sCD163 was highly correlated with other macrophage markers and was significantly elevated (median [25-75 percentiles], 4.6 mg/L [2.8-8.9]) compared with healthy controls (2.7 mg/L [2.1-3.3], p < .0001). Increased levels were observed in patients who needed intensive care (hemodialysis, p = .0011; hypotension, p = .0014; mechanical ventilation, p = .0019). Significantly lower levels of sCD163, ferritin, transcobalamin, and suPAR (but not C-reactive protein) were measured in patients > or =75 yrs. In patients <75 yrs, all macrophage markers were increased in patients who died from their infection compared with survivors, whereas no change was observed in any of the markers in the very old age. At cutoff levels of 9.5 mg/L (sCD163) and 1650 nmol/L (C-reactive protein), the relative risk for fatal outcome in patients <75 yrs was 10.1 (95% confidence interval 3.4-31.0) and 7.0 (95% confidence interval 2.4-21.6) for sCD163 and C-reactive protein, respectively. In a multivariate logistic regression model for patients <75 yrs, ferritin, transcobalamin, neopterin, and suPAR contained no significant information on the probability of survival when sCD163 and CRP were known (p = .25). CONCLUSIONS: Macrophage marker response in pneumococcal bacteremia was compromised in old age. In patients <75 yrs old, sCD163 was superior to other markers, including C-reactive protein, in predicting fatal disease outcome.
Original languageEnglish
JournalCritical Care Medicine
Volume34
Issue number10
Pages (from-to)2561-6
Number of pages5
ISSN0090-3493
DOIs
Publication statusPublished - 2006

    Research areas

  • Adult, Age Factors, Aged, Aged, 80 and over, Antigens, CD, Antigens, Differentiation, Myelomonocytic, Bacteremia, Biological Markers, Case-Control Studies, Female, Humans, Logistic Models, Macrophage Activation, Male, Middle Aged, Multivariate Analysis, Pneumococcal Infections, Prognosis, Receptors, Cell Surface, Sensitivity and Specificity, Streptococcus pneumoniae, Survival Analysis

ID: 32507315